Search results
When psoriasis becomes psoriatic arthritis
Medical News Today· 3 days agoPsoriatic arthritis (PsA) is a chronic, inflammatory condition affecting the joints and tendons. It most commonly occurs in people with existing...
These Pictures Will Help You Identify the Most Common Skin Rashes
Prevention via Yahoo News· 3 days agoFrom eczema to allergic reactions to bug bites, here’s what common skin rashes look like in photos,...
Arthritis Medications: NSAIDs, Steroids, Narcotics, Topical Treatments, and More
WebMD· 4 days agoThere are dozens of medications available with or without a prescription to treat the various forms of arthritis. Nonsteroidal anti-inflammatory drugs or NSAIDs are available both over the counter and by prescription.
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 3 days agoShares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 6 days agoEntresto...model estimate of $1.66 billion. Cosentyx’s sales (psoriasis, spondylitis, arthritis)...
Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey
ETF DAILY NEWS· 4 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...
What Are the Most Effective Psoriasis Therapy Options?
Verywell Health via Yahoo News· 6 days agoWith many treatment options for psoriasis, how do you know which ones are right for you? Here are...
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 6 days ago/Vocinti sales were 49.30 billion yen for the three months ended Dec. 31, 2023, up 11.80% year over year due to its competitive advantages in treating...
Barrington Research Reaffirms Outperform Rating for Option Care Health (NASDAQ:OPCH)
ETF DAILY NEWS· 1 day agoBarrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH –...
Bristol-Myers Squibb Expected to Earn Q2 2024 Earnings of $1.76 Per Share (NYSE:BMY)
ETF DAILY NEWS· 12 hours agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Equities research analysts at Leerink Partnrs lowered their Q2 2024 EPS estimates for shares of Bristol-Myers Squibb in a report issued on Thursday ...
